How do you position a healthtech company for clinical and economic buyers at once?

The scene I keep watching in healthtech demos

Watch a healthtech demo long enough and you can almost time the second it breaks. The clinical lead is leaning in. The product does something real, something they've wanted for years. Then the CFO, who dialed in ten minutes late, asks the only question she came to ask. What does this cost us, and what do we get back? And the room goes quiet. Not because nobody has an answer. Because the whole story was built for one buyer, and two of them showed up.

This is the healthtech founder's specific trap. You're not selling to a person. You're selling to a committee that doesn't agree with itself. The clinician wants to know it's safe, it works, and it won't wreck their workflow on a Tuesday morning. The economic buyer wants to know it pays for itself before the next budget cycle. Same product. Two completely different questions. Most companies answer one of them beautifully and fumble the other.

Here's the short version. You position a healthtech company for clinical and economic buyers by building one narrative with two proof layers, not two separate messages. The story stays fixed: the buyer you serve, the old way that's failing them, the change you deliver. What flexes is the proof. The clinician gets outcomes, safety, and workflow fit. The economic buyer gets return, risk reduction, and speed to value. One truth, told so both people recognize themselves in it.

Most healthtech companies don't have a positioning problem with each buyer. They have an averaging problem. They blend both buyers into one composite that doesn't exist anywhere, write to that ghost, and land with neither the clinician nor the CFO. This is just truth.

What's actually broken when you write for two buyers at once?

The instinct is to write to "the healthcare buyer." There is no such person. There's a nurse manager who's been burned by three tools that promised to save time and cost her an hour a day. There's a CFO staring at a budget that got tighter this year, not looser. When you write to the average of those two people, you write to nobody. You get a homepage that says "AI-powered platform for modern health systems," which is the fastest way to sound exactly like the ten vendors already in the RFP. I wrote up the deeper version of that trap in how do we differentiate when everyone claims the same benefits.

I call this Solution-Centric Marketing, and it's the thing I fight for a living. It's when your message is a feature list instead of a story, so every buyer has to do the translation work themselves. The clinician squints and tries to figure out if it's safe. The CFO squints and tries to figure out if it's worth it. You've made both of them work, and buyers who have to work to understand you don't champion you. The fix is a Magnetic Messaging Framework (MMF), the documented brand story that names who you serve, the old way you're against, and the change you deliver, so the proof for each buyer hangs off one spine instead of two competing pitches.

Why is this harder in 2026 than it used to be?

Three things changed at once, and they all push the same direction.

First, the room got more crowded. Gartner's research on B2B buying puts the typical buying group at six to ten people. In healthtech, it's worse. Enterprise health systems routinely pull eight to twelve stakeholders across clinical, IT, procurement, security, and finance into a single decision, and healthcare technology sales cycles now stretch twelve to eighteen months, per healthcare sales benchmarks reported by firms like Sagefrog and MarketBetter. Every one of those people has to see themselves in your story, and most stories only have room for one.

Second, money got tighter. The clinical "it works" argument used to be enough to earn a pilot. Now finance is in the room from day one, and "it works" without "it pays" dies in procurement. Third, and this is the one founders miss, the buyer does most of the research before you ever meet. A lot of the shortlist gets built by a clinician typing questions into ChatGPT, or an economic buyer asking Perplexity which vendors are worth a call. AI brought the cost of content to zero, so volume is no longer the moat. A clear, consistent story is. Brand is the new backlink now: if your narrative isn't sharp enough for a machine to summarize, you don't make the list the humans argue over.

This is the shift I broke down in what changes about B2B positioning when AI is doing the buyer research. The buyer's first conversation about you happens without you. If that conversation can't hold both the clinical thread and the economic thread, you're out before the demo ever gets booked.

How do you position for both buyers? Run these four plays.

You don't need two decks. You need one narrative disciplined enough to carry two kinds of proof. Here's how to build it.

1. 1Write both truths down, separately, before you write a word of copy. The clinical truth: does it work, is it safe, does it fit the workflow without adding steps? The economic truth: what does it cost, what does it return, and how fast? Get both on paper. Then find the one story that makes both true at the same time. That story, not the feature list, is your position.
2. 2Lead with the shared villain, not your features. The clinician and the CFO rarely agree on solutions, but they almost always agree on the enemy: the status quo that's burning clinical time and money at the same time. Name that villain. Villain framing is one of the four anchors of the Magnetic Messaging Framework, and it's the one that unites a split room, because the enemy is the one thing both buyers already resent.
3. 3Arm your clinical champion to make the economic case for you. Your champion is almost always a clinician, and they'll be in the CFO's office when you're not. If they can only repeat the clinical story, your deal stalls the moment it hits finance. Hand them one clean sentence that turns your outcome into money. I broke down why this fails in why can't our champion sell us to the buying committee: a champion who can't carry your economic argument isn't a champion, they're a fan.
4. 4Make your homepage pass the Three Questions Test for both buyers in five seconds. Who is this for, what problem does it solve, what's the point of view? A clinician should get an answer in five seconds. An economic buyer should get one too. If your page only answers for one of them, you've told the other they're not who you built this for. That's the fastest way to lose the buyer who signs the check, or the buyer who has to use the thing every day.

What I see across more than 100 healthtech companies

The pattern is almost boringly consistent. Nine out of ten healthtech companies I look at lead with the clinical story and bolt the ROI on at the end like a disclaimer. It makes sense. The founder is usually a clinician, or a clinically obsessed engineer, and the clinical story is the one they love. But love isn't strategy.

What happens next is predictable. The clinical champion falls for the product, carries it into the committee, and then can't answer the CFO's question. The deal doesn't die from a "no." It dies from a "not this budget cycle," which is the polite version of "you never made the money case." This is the exact failure I described in our product is great but customers don't understand the value. Great product, buried value, stalled deal.

The companies that break out of the twelve-to-eighteen-month grind aren't the ones with the best clinical data. They're the ones whose story a busy clinician can repeat in one breath and a CFO can defend in one line. Same truth, two doors in.

A real example

Here's one, composited from a few similar engagements so I'm not naming anyone. A clinical-workflow software company, roughly $18M in revenue, sold beautifully to clinicians. Their demos were incredible. Nurses and physicians would light up. And their pipeline was a graveyard of pilots that never converted into system-wide contracts.

When we pulled the story apart, the problem was obvious. Everything, the homepage, the deck, the one-pager, spoke fluent clinician and stone silence to finance. The word "ROI" showed up once, on slide 34. We rebuilt it around a single narrative: the old way, fragmented workflows costing both clinical hours and margin, versus the new way, their platform, with a promised-land outcome both buyers could see. Then we split the proof. Clinical outcomes and workflow fit for the clinician. Time recaptured, translated into dollars, for the CFO. Same story. Two proof layers.

The change wasn't a new product. It was a message their clinical champions could carry into a finance meeting without losing the thread. Pilots that used to stall at procurement started converting, because for the first time the economic buyer heard a number, not a nod. That's the whole move. Nothing about the software changed. The story finally had room for the person who signs.

What this means for you

If you're a healthtech founder watching great demos turn into dead pilots, the problem probably isn't your product and it isn't your clinical story. It's that your clinical story is doing all the work and your economic story is doing none. You built for the buyer you love and left the buyer who pays to figure it out on their own.

The fix is a documented Magnetic Messaging Framework: one narrative spine, with the clinical proof and the economic proof both hanging off it, so every stakeholder in that twelve-person committee hears the same truth in their own language. That's what a Magnetic Messaging Framework does. It gives your champion the words to sell you when you're not in the room, and it gives an AI engine a story clear enough to put you on the shortlist before the committee ever meets. Get that right and the whole deal gets shorter, because nobody has to translate you anymore.

Here's what to do this week:

1. 1Write your clinical truth and your economic truth on two separate lines. If you can't state the economic one in a single sentence a CFO would nod at, that's your gap, and it's not a data problem.
2. 2Read your homepage as the CFO, not the clinician. Cover the logo. In five seconds, does it tell an economic buyer this was built for their problem too? If not, you're only selling half the room.
3. 3Hand your best clinical champion one sentence that turns your outcome into money, and ask them to say it back to you. If they can't, rewrite it until they can. That sentence is worth more than your next feature.

PitchKitchen builds Magnetic Messaging Frameworks for founder-led B2B companies in the $5M-$75M range, including healthtech companies stuck selling to clinicians while the economic buyer tunes out. Greg Rosner, founder of PitchKitchen and author of Story Craft for Disruptors, developed the Magnetic Messaging Framework across more than 300 founder engagements. The move is always the same: one truth, told so every buyer in the room recognizes themselves in it.